When the stakes are so high, the decision to commercialize an approved drug or vaccine must be well-founded. What is the market potential of the treatment being investigated? How far along are competitors with their development pipelines? What are the chances of success? Careful consideration - and a robust knowledge platform - help win the race.
The importance of post-launch KOLs cannot be underestimated. In their role as educators and influencers of their peers, they can contribute significantly to product awareness and provide valuable information based on their personal experience of prescribing the drug. It is challenging to find appropriate experts because classifying knowledge and queries are often done manually. By identifying subject matter experts and key opinion leaders to be involved in research studies and clinical trials, DISQOVER improves finding experts based on experience.
Traditionally, new drug discoveries arise from medical needs or commercial potential. But what if we discover new scientific opportunities based on existing publications and patents? Shifting existing literature for evidence relating to a research topic is a core element of life sciences research during commercialization. With DISQOVER's unique features, finding, assembling, and curating that evidence become a lot less time-consuming – enhancing productivity and giving you a leg up on your competition.
